about
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of C...
Read More
4.18
-0.42
(-9.13%)
6.3M
XNAS Volume
High volume+loss today
XNAS 10 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for I-Mab - ADR is on 11 Sep 2025 for the purpose of I-MAB Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
IMab ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..